Upload
vuduong
View
214
Download
0
Embed Size (px)
Citation preview
GRAND DESIGNInnovation Center For Industrial
Advanced Pharmaceuticals (ICIAPs)
YOGYAKARTA, AGUSTUS 4TH 2015
CONCEPT OF PHARMACEUTICAL INDUSTRIES DEVELOPMENT
INPUT OUTPUT OUTCOME
EXCELLENT HUMAN RESOURCES
QUALIFIED PHARMACEUTICAL PRODUCTS
VALID & ADVANCED MEDICAL DEVICES
RND INSTITUTIONS
UNIVERSITIES
MINISTRY OF RESEARCH
MINISTRY OF FINANCE
MINISTRY OF INDUSTRY
MINISTRY OF HEALTH
PHARMACEUTICAL INDUSTRIES
DEVELOPMENT OF INNOVATIVE
PHARMACUTICAL SCIENCE-TECH
HEALTH SERVICE
INNOVATIVE PHARMACUTICALS
PRODUCT
ADVANCED TECHNOLOGY VALUE
MODERN SOCIETY NEEDS
HIGH LEVEL of NATIONAL
COMPETITIVENESS
HIGH QUALITY OF HEALTH
STATUS
PROCESS
EFFECTIVE
EFFICIENT
POWERED PHARMACEUTICAL
INDUSTRIES
2
3
SWOT ANALYSIS
Strengths
Strong Networking
with Strategic
Institution
Track record of
UGM as World
Class University
Excellent Human
Resources
Opportunities
Innovative Product
Promising Market
Opportunities
Weaknesses
Uncompetitive
Indonesian
Pharmaceutical
Industries
Lack of the National
Research Fund
Lack of TRL-5 to
TRL-9 Facilities
Stagnancy of
Indonesian
Pharmaceutical
Research Downstream
Threat
Globalization
ASEAN
Harmonization
Lack of Potential
Indonesian Human
Resources
Invasion of Import
Innovative Product
ICIAPs RESOURCES
ICIAPs
MINISTRY OF RESEARCH
MINISTRY OF INDUSTRY
BATAN
LIPI
UGM ASSETSKIMIA FARMA
BIOFARMA
NAIST
4
KURRI
STELLA PHARMA & SUMITOMO HEAVY
INDUSTRY
RESOURCES OUTPUTPROCESS
TECHNOLOGY TRANSFER
DRUGS
BIOPHARMACEUTICALS
OUTPUT OF INNOVATION CENTER OF ADVANCED PHARMACEUTICALSUNIVERSITAS GADJAH MADA
PATENT
INTERNATIONAL PUBLICATION
GRADUATE STUDENT
ADVANCED PRODUCT
TRL 5-9
ICIAPs
PUBLIC POLICYFEEDBACK
GOVERNMENT POLICY
COSMETICS, PHYTOPHARMACA, NANOPHARMACEUTICALS
MINISTRY OF INDUSTRY
MINISTRY OF RESEARCH
BATAN
LIPI
UGM ASSETS
KIMIA FARMA
BIOFARMA
NAIST
PHARMACEUTICAL INDUSTRY READINESS
5
ROADMAP OF ICIAPs
TARGET 2015: TARGET 2016: TARGET 2017: TARGET 2018:
1. Rector Decree Issued forICIAPs OrganizationStructure
2. Ratification of MoU withMinistry of IndustryRepublic of Indonesia
3. Establishment of ICIAPsMaster Plan
4. Document Establishmentof Selected Pilot PlantProject
1.Setting up ICIAPs Construction:• The Building is settle,
tools and instruments are already available
2.Setting up Selected Pilot Plant Production• Establishment of
Validation and Qualification Plant
3.Screening of PotentialInnovative Pharmaceuticals Product• Profile of others
innovative pharmaceuticals product, cosmetics, phytopharmaca
1. Evaluation & Improvement of ICIAPs
2. Validation of Pilot Scale Production
3. Expansion of innovative advanced pharmaceuticals
1.Expansion of cooperation & networking:• Strengthening of
networking withadvanced pharmaceutical technology institution
2.Product Downstream3.Evaluation &
Improvement of ICIAPs4.Development of Pilot
Scale Production
STRENGTHENING THE NATIONAL INNOVATION SYSTEM ON THE FIELD OF MEDICAL AND PHARMACEUTICAL FOR NATION INDEPENDENCE BASED ON SCIENTECH ADVANTAGES
6
STRUCTURE OF ICIAPs
7
Director & Vice Director of ICIAPs
RnDDivision
University Sub Division
ADVISOR
RECTOR
Networking & Marketing Division
Biological Sub Division
Chemical Sub Division
Industry Sub Division
RnD Institution Sub Division
Chemical Analysis
Formulation and Scale
Up
Biological Synthesis
Effication& Safety
Organic Syntesis &
Preparation
Clinical Test
BiologicalAnalysis
NAIST COLLABORATION BENEFIT EXCHANGES
8
UGM
TECHNOLOGY TRANSFER
SCIENTIFIC MERIT EXPAND
STAFF/STUDENT EXCHANGE
INTERNATIONAL PUBLICATION
SUPERVISOR PATENT